Molecular diversity of HIV in Albania

被引:25
作者
Ciccozzi, M
Gori, C
Boros, S
Ruiz-Alvarez, MJ
Harxhi, A
Dervishi, M
Qyra, S
Schinaia, N
D'Arrigo, R
Ceccherini-Silberstein, F
Bino, S
Perno, CF
Rezza, G
机构
[1] Ist Super Sanita, Dept Infect Dis, Epidemiol Unit, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[3] Infect Dis Hosp, Mother Theresa Med Ctr, Tirana, Albania
关键词
D O I
10.1086/431599
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little information is available on circulating human immunodeficiency virus (HIV) subtypes and resistance to antiretroviral drugs in Albania. To fill this gap, we studied 72 plasma samples from HIV-infected individuals from throughout the country. Subtype classification and genotypic resistance analysis were performed on the HIV pol gene region. The analysis was successfully performed on 66 (91.6%) plasma samples and showed that 43 (65.2%) strains were non-B subtypes (mostly subtype A, as determined by analysis of pol gene sequences). No major mutations in the protease gene were found, whereas analysis of the reverse transcriptase gene revealed a few major mutations associated with resistance. In conclusion, non-B subtypes are predominant in Albania, and the prevalence of resistance to antiretroviral drugs is still low.
引用
收藏
页码:475 / 479
页数:5
相关论文
共 15 条
  • [1] Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012
  • [2] A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union:: Identification of subtype A, subtype B, and novel gagA/envB recombinants
    Bobkov, A
    Kazennova, E
    Selimova, L
    Bobkova, M
    Khanina, T
    Ladnaya, N
    Kravchenko, A
    Pokrovsky, V
    Cheingsong-Popov, R
    Weber, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (08) : 669 - 676
  • [3] *EUR CTR EPID MON, 2003, HIV SURV EUR MID YEA
  • [4] Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
  • [5] HIV in central and eastern Europe
    Hamers, FF
    Downs, AM
    [J]. LANCET, 2003, 361 (9362) : 1035 - 1044
  • [6] HARXHI A, 2002, RAPID ASSESSMENT RES
  • [7] Johnson Victoria A, 2003, Top HIV Med, V11, P215
  • [8] Jukes TH, 1969, MAMMALIAN PROTEIN ME, P21, DOI [DOI 10.1016/B978-1-4832-3211-9.50009-7, DOI 10.1093/BIOINFORMATICS/BTM404]
  • [9] Genotypic characterization of human immunodeficiency virus type 1 in Greece
    Nasioulas, G
    Paraskevis, D
    Paparizos, V
    Lazanas, M
    Karafoulidou, A
    Hatzakis, A
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (08) : 685 - 690
  • [10] Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation
    Perno, CF
    Cozzi-Lepri, A
    Balotta, C
    Bertoli, A
    Violin, M
    Monno, L
    Zauli, T
    Montroni, M
    Ippolito, G
    d'Arminio-Monforte, A
    [J]. AIDS, 2002, 16 (04) : 619 - 624